2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

AIMThis executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. METHODSA comp...

Full description

Saved in:
Bibliographic Details
Published inCirculation (New York, N.Y.) Vol. 142; no. 25; pp. e533 - e557
Main Authors Ommen, Steve R., Mital, Seema, Burke, Michael A., Day, Sharlene M., Deswal, Anita, Elliott, Perry, Evanovich, Lauren L., Hung, Judy, Joglar, José A., Kantor, Paul, Kimmelstiel, Carey, Kittleson, Michelle, Link, Mark S., Maron, Martin S., Martinez, Matthew W., Miyake, Christina Y., Schaff, Hartzell V., Semsarian, Christopher, Sorajja, Paul
Format Journal Article
LanguageEnglish
Published United States by the American College of Cardiology Foundation and the American Heart Association, Inc 22.12.2020
Subjects
occupation
risk stratification
echocardiography
systolic dysfunction
sudden cardiac death
left ventricular outflow tract obstruction
septal alcohol ablation
AHA Scientific Statements
sarcomeric genes
atrial fibrillation
genetics
shared decision-making
guidelines
family screening
rhythm monitoring
pregnancy
septal reduction therapy
cardiovascular magnetic resonance
physical activity
exercise stress testing
implantable cardioverter defibrillator
surgical myectomy
ventricular arrhythmias
diastolic dysfunction
hypertrophic cardiomyopathy
Online AccessGet full text

Cover

Abstract AIMThis executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. METHODSA comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. STRUCTUREMany recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.
AbstractList Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. Methods A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Structure Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. Methods A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Structure Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. Methods A comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. Structure Many recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.
AIMThis executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and manage hypertrophic cardiomyopathy in adult and pediatric patients as well as supporting documentation to encourage their use. METHODSA comprehensive literature search was conducted from January 1, 2010, to April 30, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relevant databases. STRUCTUREMany recommendations from the earlier hypertrophic cardiomyopathy guidelines have been updated with new evidence or a better understanding of earlier evidence. This summary operationalizes the recommendations from the full guideline and presents a combination of diagnostic work-up, genetic and family screening, risk stratification approaches, lifestyle modifications, surgical and catheter interventions, and medications that constitute components of guideline directed medical therapy. For both guideline-directed medical therapy and other recommended drug treatment regimens, the reader is advised to follow dosing, contraindications and drug-drug interactions based on product insert materials.
Author Deswal, Anita
Link, Mark S.
Martinez, Matthew W.
Ommen, Steve R.
Kimmelstiel, Carey
Schaff, Hartzell V.
Sorajja, Paul
Burke, Michael A.
Kittleson, Michelle
Day, Sharlene M.
Maron, Martin S.
Mital, Seema
Elliott, Perry
Kantor, Paul
Semsarian, Christopher
Evanovich, Lauren L.
Hung, Judy
Joglar, José A.
Miyake, Christina Y.
AuthorAffiliation Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. ACC/AHA Representative. ACC/AHA Joint Committee on Clinical Practice Guidelines Liaison. HFSA Representative. ASE Representative. HRS Representative. SCMR Representative. AATS Representative. SCAI Representative
AuthorAffiliation_xml – name: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. ACC/AHA Representative. ACC/AHA Joint Committee on Clinical Practice Guidelines Liaison. HFSA Representative. ASE Representative. HRS Representative. SCMR Representative. AATS Representative. SCAI Representative
– name: SCAI Representative
– name: ACC/AHA Representative
– name: SCMR Representative
– name: AATS Representative
– name: ASE Representative
– name: HRS Representative
Author_xml – sequence: 1
  givenname: Steve
  surname: Ommen
  middlename: R.
  fullname: Ommen, Steve R.
  organization: Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry may apply; see Appendix 1 for detailed information. ACC/AHA Representative. ACC/AHA Joint Committee on Clinical Practice Guidelines Liaison. HFSA Representative. ASE Representative. HRS Representative. SCMR Representative. AATS Representative. SCAI Representative
– sequence: 2
  givenname: Seema
  surname: Mital
  fullname: Mital, Seema
– sequence: 3
  givenname: Michael
  surname: Burke
  middlename: A.
  fullname: Burke, Michael A.
– sequence: 4
  givenname: Sharlene
  surname: Day
  middlename: M.
  fullname: Day, Sharlene M.
– sequence: 5
  givenname: Anita
  surname: Deswal
  fullname: Deswal, Anita
– sequence: 6
  givenname: Perry
  surname: Elliott
  fullname: Elliott, Perry
– sequence: 7
  givenname: Lauren
  surname: Evanovich
  middlename: L.
  fullname: Evanovich, Lauren L.
– sequence: 8
  givenname: Judy
  surname: Hung
  fullname: Hung, Judy
– sequence: 9
  givenname: José
  surname: Joglar
  middlename: A.
  fullname: Joglar, José A.
– sequence: 10
  givenname: Paul
  surname: Kantor
  fullname: Kantor, Paul
– sequence: 11
  givenname: Carey
  surname: Kimmelstiel
  fullname: Kimmelstiel, Carey
– sequence: 12
  givenname: Michelle
  surname: Kittleson
  fullname: Kittleson, Michelle
– sequence: 13
  givenname: Mark
  surname: Link
  middlename: S.
  fullname: Link, Mark S.
– sequence: 14
  givenname: Martin
  surname: Maron
  middlename: S.
  fullname: Maron, Martin S.
– sequence: 15
  givenname: Matthew
  surname: Martinez
  middlename: W.
  fullname: Martinez, Matthew W.
– sequence: 16
  givenname: Christina
  surname: Miyake
  middlename: Y.
  fullname: Miyake, Christina Y.
– sequence: 17
  givenname: Hartzell
  surname: Schaff
  middlename: V.
  fullname: Schaff, Hartzell V.
– sequence: 18
  givenname: Christopher
  surname: Semsarian
  fullname: Semsarian, Christopher
– sequence: 19
  givenname: Paul
  surname: Sorajja
  fullname: Sorajja, Paul
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33215938$$D View this record in MEDLINE/PubMed
BookMark eNqFUs1u1DAYtFAR3RbeACEfuaTrvySb3qJQukWVqEoRx8jrfNkYnDjYDmUfmzfA6ZaCeqC-2B7PjL_PniN0MNgBEHpNyQmlGV1WF9cn5N9R8NUztKApE4lIeXGAFjOY5JyxQ3Tk_de4zXievkCHnDOaRv4C_WKEEVyuy2VZVfh80g0YPQBurcOhA_xOy-1gvfZYDg2-cSBDD0PAtsVXMui49PiLDh1e70Zwwdmx0wpX0jXa9js7ytDtTvHZT1BT0D8Af5r6XroIlfgaRuvunOaLyh6cVnLAlTUGtjDjextjt7vlw_EaZBSV3lulYwF2wB-sjgVVtu91CBCF0SP2ENkGXzmpglbwtzP_Ej1vpfHw6n4-Rp_fn91U6-Ty4_lFVV4mShC6SiBrhQQFQjSKFJK1RZ5nnG5YWqzylOa8JYoCzVMuWwZqk5NGbjKRU56RtFWCH6O3e9_R2e8T-FD32iswRg5gJ18zkXFSFIyySH1zT502PTT16PT8SPWfb4oEsScoZ7130D5QKKnnNNQxDfXjNETZ6SOZ0uHu0YKT2jwlXu3Ft9YEcP6bmW7B1R1IE7qnpOI_0pnFCc2TOXqUMUaSiNCC_waYXtw5
CitedBy_id crossref_primary_10_3389_fcvm_2023_1168514
crossref_primary_10_46563_1560_9561_2022_25_2_96_105
crossref_primary_10_1161_CIRCOUTCOMES_123_010243
crossref_primary_10_1161_CIRCEP_121_010075
crossref_primary_10_31083_j_rcm2502038
crossref_primary_10_1161_CIRCRESAHA_123_323272
crossref_primary_10_1007_s40256_023_00599_0
crossref_primary_10_1161_CIRCGEN_120_003259
crossref_primary_10_1007_s40119_022_00260_y
crossref_primary_10_1002_ejhf_3339
crossref_primary_10_3390_life14020200
crossref_primary_10_1016_j_amjcard_2021_07_025
crossref_primary_10_24969_hvt_2024_500
crossref_primary_10_1007_s12410_023_09588_y
crossref_primary_10_3390_ijms24054724
crossref_primary_10_31083_RCM25132
crossref_primary_10_7759_cureus_70550
crossref_primary_10_1002_clc_70095
crossref_primary_10_1161_CIRCHEARTFAILURE_121_008738
crossref_primary_10_3390_jcm10050951
crossref_primary_10_1007_s40256_023_00580_x
crossref_primary_10_1111_echo_15437
crossref_primary_10_1161_JAHA_121_021970
crossref_primary_10_1161_JAHA_123_034080
crossref_primary_10_3390_jcm12010225
crossref_primary_10_1002_ejhf_2997
crossref_primary_10_1161_JAHA_121_024566
crossref_primary_10_1161_CIRCINTERVENTIONS_121_011686
crossref_primary_10_3389_fcvm_2022_1051564
crossref_primary_10_31083_RCM25045
crossref_primary_10_1111_echo_70108
crossref_primary_10_3389_fcvm_2024_1359657
crossref_primary_10_3389_fcvm_2021_766339
crossref_primary_10_24969_hvt_2020_231
crossref_primary_10_24969_hvt_2023_403
crossref_primary_10_20996_1819_6446_2021_06_06
crossref_primary_10_3389_fmed_2024_1480947
crossref_primary_10_31083_j_rcm2304141
crossref_primary_10_1161_CIRCULATIONAHA_122_062517
crossref_primary_10_3389_fcvm_2021_695247
crossref_primary_10_1161_JAHA_122_026025
crossref_primary_10_17816_cardar567837
crossref_primary_10_1161_JAHA_121_024220
crossref_primary_10_3390_jcdd12030101
crossref_primary_10_3389_fcvm_2022_882662
crossref_primary_10_18087_cardio_2021_12_n1718
crossref_primary_10_1186_s12872_024_04135_z
crossref_primary_10_20514_2226_6704_2023_13_4_282_293
crossref_primary_10_3389_fped_2021_708679
crossref_primary_10_31083_j_rcm2409252
crossref_primary_10_1002_ehf2_14848
crossref_primary_10_3390_ph17101364
crossref_primary_10_1161_JAHA_123_034069
crossref_primary_10_1007_s10741_023_10355_w
crossref_primary_10_1155_2022_6436073
crossref_primary_10_1007_s11936_021_00942_1
crossref_primary_10_1001_jamainternmed_2023_5251
crossref_primary_10_1161_JAHA_121_024501
crossref_primary_10_1002_ehf2_15010
crossref_primary_10_1002_mgg3_2290
crossref_primary_10_47102_annals_acadmedsg_2022344
crossref_primary_10_1038_s41598_022_19895_x
crossref_primary_10_1161_JAHA_122_029930
crossref_primary_10_3389_fcvm_2023_1282587
crossref_primary_10_3389_fcvm_2022_758975
crossref_primary_10_31083_j_rcm2312391
crossref_primary_10_15825_1995_1191_2022_2_58_64
crossref_primary_10_4274_imj_galenos_2022_90757
crossref_primary_10_1007_s00399_022_00884_6
crossref_primary_10_1161_CIRCULATIONAHA_123_065600
crossref_primary_10_3390_jcm11123405
crossref_primary_10_3389_fcvm_2022_972301
crossref_primary_10_4330_wjc_v17_i1_99595
crossref_primary_10_1007_s12055_023_01661_x
crossref_primary_10_1021_acsami_4c22895
crossref_primary_10_17116_kardio2024170117
crossref_primary_10_1161_JAHA_124_036593
crossref_primary_10_3389_fcvm_2024_1403422
crossref_primary_10_1002_ejhf_3120
crossref_primary_10_3389_fgene_2022_894791
crossref_primary_10_3389_fcvm_2022_849882
crossref_primary_10_1155_2023_4611602
crossref_primary_10_2147_JMDH_S292945
crossref_primary_10_1002_ejhf_3408
crossref_primary_10_3389_fcvm_2023_1190181
crossref_primary_10_3390_jcdd10060226
crossref_primary_10_1161_CIRCRESAHA_122_319835
crossref_primary_10_3389_fcvm_2021_694240
crossref_primary_10_29001_2073_8552_2022_37_3_65_74
crossref_primary_10_1161_JAHA_124_033767
crossref_primary_10_2147_VHRM_S365001
crossref_primary_10_3389_fradi_2022_881777
crossref_primary_10_3390_ijms221910401
crossref_primary_10_57187_s_3891
crossref_primary_10_4330_wjc_v16_i11_651
crossref_primary_10_3389_fcvm_2022_831918
crossref_primary_10_3389_fmed_2024_1507313
crossref_primary_10_3390_diagnostics12051104
crossref_primary_10_3389_fphys_2022_976315
crossref_primary_10_1186_s12916_024_03301_6
crossref_primary_10_1161_JAHA_121_024656
crossref_primary_10_1001_jamacardio_2024_2781
crossref_primary_10_3390_diagnostics13091544
crossref_primary_10_1161_JAHA_123_031399
crossref_primary_10_3389_fcvm_2023_1278457
crossref_primary_10_3389_fcvm_2024_1387596
crossref_primary_10_1161_JAHA_123_032520
crossref_primary_10_1002_jgc4_1602
crossref_primary_10_1111_echo_15857
crossref_primary_10_17116_hirurgia202106231
crossref_primary_10_3389_fcvm_2022_834738
crossref_primary_10_1161_JAHA_120_019978
crossref_primary_10_1007_s00246_022_02867_3
crossref_primary_10_3389_fped_2023_1295539
crossref_primary_10_7759_cureus_55823
crossref_primary_10_1002_ehf2_14762
crossref_primary_10_1007_s11936_021_00921_6
crossref_primary_10_3389_fphar_2023_1227470
crossref_primary_10_46563_1560_9561_2023_26_3_152_158
crossref_primary_10_1038_s41598_023_49475_6
Cites_doi 10.1016/j.jacc.2015.01.019
10.1016/j.jacc.2018.05.060
10.1016/j.jacc.2012.03.076
10.1016/j.jacc.2015.03.552
10.1007/s10554-013-0355-y
10.1161/JAHA.115.002418
10.1161/01.CIR.99.22.2927
10.1016/S0894-7317(00)90026-9
10.1016/j.echo.2011.03.002
10.1016/j.amjcard.2018.06.055
10.1002/ejhf.316
10.1161/circulationaha.108.798314
10.1016/j.chest.2018.11.009
10.1161/circep.110.957290
10.1136/hrt.32.6.804
10.1111/jth.12780
10.1016/j.amjcard.2017.12.044
10.1016/0002-9149(62)90373-9
10.1016/j.jacc.2005.02.090
10.1016/S0735-1097(98)00493-8
10.1016/j.hrthm.2011.07.017
10.1016/j.jcmg.2015.04.006
10.1016/j.jjcc.2014.02.011
10.1016/j.hlc.2015.07.008
10.1161/circulationaha.104.507723
10.1016/j.jacc.2018.04.078
10.1056/NEJMoa075463
10.1093/eurheartj/ehm117
10.1136/bjsports-2016-097438
10.1016/j.amjcard.2014.07.075
10.1161/circulationaha.107.742395
10.1161/CIRCGEN.119.002460
10.1016/j.jacc.2004.12.067
10.1093/eurheartj/ehx731
10.1161/circulationaha.105.583500
10.1038/s41436-019-0478-1
10.1093/ejcts/ezx017
10.1093/eurheartj/ehz396
10.1016/0002-9149(73)90012-X
10.1001/jama.2009.371
10.1016/j.mayocp.2018.07.022
10.1111/pace.13310
10.1016/j.jacc.2018.09.064
10.1016/j.jtcvs.2017.08.063
10.1016/j.jtcvs.2018.11.148
10.1016/j.healun.2015.03.012
10.1016/j.echo.2011.03.006
10.1038/nrcardio.2017.6
10.1016/j.hrthm.2015.03.042
10.1056/NEJMoa1510687
10.1093/eurheartj/ehr092
10.1016/j.jacc.2017.11.040
10.1161/CIRCINTERVENTIONS.118.007673
10.1161/CIRCEP.117.004801
10.1536/ihj.27.701
10.1097/FJC.0b013e31829651fe
10.1016/j.amjcard.2006.07.029
10.1016/j.echo.2017.11.016
10.1016/j.jtcvs.2011.10.096
10.1161/01.CIR.64.4.787
10.1161/circulationaha.106.644682
10.1016/j.jcin.2011.02.014
10.1016/j.ejrad.2014.05.035
10.1136/hrt.2003.014969
10.1016/j.ahj.2013.06.009
10.1093/ejechocard/jeq063
10.1016/j.amjcard.2013.01.340
10.1016/j.ijcard.2011.07.095
10.1093/europace/eux163
10.1111/j.1542-474X.2001.tb00118.x
10.1016/j.jtcvs.2018.08.062
10.1016/0002-9149(89)90187-2
10.1111/j.1540-8167.2008.01320.x
10.1161/CIR.0000000000000678
10.1038/gim.2015.30
10.1093/eurheartj/ehq136
10.1161/CIRCULATIONAHA.111.090514
10.1093/eurheartj/ehs150
10.1001/jamacardio.2019.1391
10.1161/01.cir.0000162460.36735.71
10.1016/S0002-9149(99)80416-0
10.1016/j.echo.2010.10.006
10.1023/B:JICE.0000035929.84238.2f
10.1161/CIRCULATIONAHA.117.033200
10.1093/eurheartj/ehx042
10.1038/gim.2012.19
10.1016/j.ijcard.2017.07.015
10.1016/j.mayocp.2016.01.002
10.1093/oxfordjournals.eurheartj.a015435
10.1016/j.jcmg.2016.02.031
10.1093/europace/euz118
10.1161/circimaging.115.003132
10.1161/CIR.0000000000000503
10.1161/CIRCULATIONAHA.117.031306
10.1016/j.athoracsur.2009.10.065
10.1056/NEJMoa021332
10.1016/0735-1097(92)90359-U
10.1093/eurheartj/ehy340
10.1161/CIRCIMAGING.116.005372
10.1016/j.amjcard.2007.09.111
10.1016/0735-1097(93)90386-F
10.1056/NEJMsa1507092
10.1093/eurheartj/ehu112
10.1161/JAHA.115.002488
10.1016/j.jacc.2016.01.071
10.1016/S0735-1097(83)80269-1
10.1161/CIRCULATIONAHA.117.030437
10.1161/CIRCULATIONAHA.117.027828
10.1136/heartjnl-2018-313058
10.1161/CIRCGENETICS.117.001916
10.1111/cge.13157
10.1016/0735-1097(92)90135-A
10.1093/eurheartj/ehv522
10.1067/mje.2000.108250
10.1161/JAHA.117.006937
10.1016/j.ajog.2019.07.019
10.1016/j.jacc.2012.02.068
10.1161/CIRCULATIONAHA.119.044366
10.1136/hrt.2010.217182
10.1016/S0735-1097(99)00056-X
10.1161/JAHA.116.005152
10.1016/j.euje.2004.01.001
10.1161/01.CIR.60.6.1208
10.1016/j.hrthm.2016.03.004
10.1016/S0735-1097(02)02495-6
10.1007/s00246-011-9967-y
10.1016/j.echo.2017.11.013
10.1253/circj.CJ-16-0432
10.1161/CIRCULATIONAHA.107.698985
10.1007/s10554-013-0358-8
10.1161/01.CIR.67.2.413
10.1038/gim.2014.205
10.1016/j.jcmg.2008.09.002
10.1161/circimaging.110.957936
10.1016/j.jacc.2020.04.045
10.1007/s12471-012-0358-7
10.1016/j.jacc.2013.01.037
10.1016/j.hrthm.2017.11.020
10.1093/europace/euv339
10.1016/j.amjcard.2003.10.025
10.1253/circj.CJ-16-0428
10.1016/j.ijcard.2017.08.010
10.1093/eurheartj/eht439
10.1093/ehjci/jew313
10.1016/j.amjcard.2013.12.034
10.1136/hrt.2003.031161
10.1136/heartjnl-2013-305471
10.1016/j.amjcard.2019.02.051
10.1161/circep.113.000339
10.1016/0735-1097(95)00390-8
10.1016/S0140-6736(00)04005-8
10.1093/ehjci/jew024
10.1016/j.jacc.2005.01.012
10.1161/01.CIR.35.5.847
10.1001/jama.2017.2503
10.1016/j.jacc.2013.03.062
10.1161/CIRCULATIONAHA.115.020252
10.1161/CIRCULATIONAHA.117.029639
10.1016/j.jacc.2015.06.1333
10.1016/S0002-9149(02)02694-2
10.1016/j.amjcard.2018.05.023
10.1161/CIRCHEARTFAILURE.112.000122
10.1161/circulationaha.111.076257
10.1016/j.hrthm.2019.04.040
10.1038/s41436-018-0391-z
10.1093/eurheartj/ehu284
10.1136/adc.62.12.1265
10.1111/jce.13121
10.1097/00005650-198903001-00010
10.1016/j.jacc.2004.11.043
10.1002/ccd.26472
10.1016/j.hrthm.2018.12.017
10.1161/HCG.0000000000000054
10.1161/circulationaha.107.738740
10.1136/jmg.2005.033886
10.1016/j.hrthm.2008.08.021
10.1161/hc4601.097997
10.1093/eurheartj/ehy730
10.1016/j.acvd.2017.05.010
10.1016/j.amjcard.2017.02.040
10.1056/NEJM200006153422403
10.1111/j.1540-8167.2010.01943.x
10.1093/europace/euw260
10.1161/01.cir.0000097110.55312.bf
10.1016/j.athoracsur.2018.03.039
10.1093/eurheartj/ehq271
10.1161/CIRCULATIONAHA.118.038846
10.1111/jce.13194
10.1016/j.transproceed.2013.12.052
10.1161/circheartfailure.114.002248
10.1016/j.jacc.2016.07.735
10.1007/BF02595921
10.1016/0002-9149(81)90604-4
10.1016/j.jtcvs.2018.03.150
10.1016/j.hrthm.2016.01.001
10.1093/eurheartj/ehw210
10.1016/j.jacc.2004.09.039
10.1016/j.jacc.2014.05.003
10.1161/CIRCULATIONAHA.118.037264
10.1136/heartjnl-2016-309406
10.1007/s00246-013-0676-6
10.1016/S0735-1097(02)01950-2
10.1111/j.1540-8167.2008.01366.x
10.1161/circheartfailure.114.001843
10.1016/j.jacc.2011.08.040
10.1016/S2213-8587(14)70241-4
10.1161/CIRCULATIONAHA.120.047235
10.1177/2047487317702519
10.1016/j.ejheart.2008.03.006
10.1016/j.jacc.2010.11.002
10.1161/circulationaha.113.007094
10.1016/j.hrthm.2010.05.022
10.1001/jamacardio.2016.0252
10.1016/0002-8703(85)90357-6
10.1016/j.amjcard.2016.11.010
10.1038/gim.2013.44
10.1007/s10554-016-0858-4
10.1161/circheartfailure.112.967026
10.1016/j.amjcard.2017.08.047
10.1097/HCO.0000000000000200
10.1161/CIR.0b013e318223e2bd
10.1093/eurheartj/ehq308
10.1136/hrt.48.3.204
10.1161/circulationaha.112.000849
10.1001/jama.298.4.405
10.1161/circheartfailure.114.001435
10.1161/01.CIR.79.5.1052
10.1093/eurheartj/ehv063
10.1161/CIRCGEN.117.001896
10.1016/j.jacc.2016.04.026
10.1016/j.amjcard.2012.04.030
10.3390/jcm7110447
10.1093/eurheartj/eht491
10.1161/CIRCULATIONAHA.117.031725
10.1111/j.1540-8167.2011.02183.x
10.1016/j.jacc.2009.05.006
10.1016/j.hrthm.2017.06.022
10.1007/s00392-015-0901-9
10.1016/j.amjcard.2017.08.048
10.1016/j.amjcard.2010.01.367
10.1161/circulationaha.117.029267
10.1016/j.jacc.2019.05.053
10.1111/jce.12982
10.1002/(SICI)1522-726X(199908)47:4<462::AID-CCD16>3.0.CO;2-9
10.1161/circulationaha.112.000447
10.1161/cir.0b013e31829e8776
10.1136/hrt.56.6.544
10.1001/jama.295.2.165
10.1016/j.amjcard.2013.05.070
10.1016/S0735-1097(03)00827-1
10.1016/S0735-1097(96)00473-1
10.1378/chest.14-1498
10.1111/cge.13024
10.1161/circheartfailure.110.959288
10.1161/circulationaha.105.594531
10.1136/hrt.2007.126003
10.1093/eurheartj/ehx189
10.1161/01.CIR.98.22.2415
10.1136/heart.89.7.752
10.1016/j.cardfail.2017.09.011
10.1016/j.amjcard.2010.01.023
10.1161/CIRCIMAGING.117.006309
10.1016/j.jacc.2009.07.030
10.1016/j.cpcardiol.2018.10.002
10.1161/circep.116.004604
10.1016/j.jcmg.2013.08.010
10.1161/circulationaha.114.013478
10.1161/CIR.0000000000000499
10.1038/gim.2013.138
10.1016/j.jpeds.2017.03.033
10.1016/j.amjcard.2012.12.026
10.1016/j.jacc.2009.01.079
10.1016/j.amjcard.2016.08.092
10.1111/echo.13158
10.1016/j.echo.2018.01.022
10.1161/circulationaha.115.017633
10.1136/heartjnl-2013-304276
10.1097/MAT.0b013e318286018d
10.7326/0003-4819-102-4-520
10.1016/S0735-1097(10)80014-2
10.1016/j.jtcvs.2013.06.046
10.1161/CIRCULATIONAHA.117.032966
10.1053/euhj.1999.1692
10.1016/j.amjcard.2015.11.016
10.1161/CIRCGENETICS.116.001620
10.1056/NEJMoa1105575
10.1136/heartjnl-2012-303271
10.1161/circulationaha.110.975219
10.1161/JAHA.114.001002
10.1007/BF03164924
10.1016/0033-0620(85)90024-6
10.1016/j.jacc.2016.11.063
10.1016/S0277-9536(98)00059-8
10.1161/CIRCGENETICS.112.963363
10.1161/cir.0000000000000311
10.1136/hrt.2007.118018
10.1016/j.amjcard.2010.06.077
10.1016/S0735-1097(01)01727-2
10.1093/eurheartj/ehx370
ContentType Journal Article
Copyright by the American College of Cardiology Foundation and the American Heart Association, Inc.
2020 by the American College of Cardiology Foundation and the American Heart Association, Inc.
Copyright_xml – notice: by the American College of Cardiology Foundation and the American Heart Association, Inc.
– notice: 2020 by the American College of Cardiology Foundation and the American Heart Association, Inc.
CorporateAuthor Writing Committee Members
CorporateAuthor_xml – name: Writing Committee Members
DBID AAYXX
CITATION
NPM
7X8
DOI 10.1161/CIR.0000000000000938
DatabaseName CrossRef
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1524-4539
EndPage e557
ExternalDocumentID 33215938
10_1161_CIR_0000000000000938
10.1161/CIR.0000000000000938
00003017-202012220-00019
Genre Journal Article
GroupedDBID ---
.-D
.3C
.XZ
.Z2
01R
0R~
0ZK
18M
1J1
29B
2FS
2WC
354
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
6PF
71W
77Y
7O~
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAWTL
AAXQO
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPMR
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACDDN
ACDOF
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACOAL
ACRKK
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADCYY
ADGGA
ADHPY
AE3
AE6
AEBDS
AENEX
AFBFQ
AFCHL
AFDTB
AFEXH
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
ASPBG
AVWKF
AYCSE
AZFZN
BAWUL
BOYCO
BQLVK
BYPQX
C45
CS3
DIK
DIWNM
DU5
E3Z
EBS
EEVPB
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
GNXGY
GQDEL
GX1
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OBH
OCB
ODMTH
OGEVE
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
PQQKQ
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
UPT
V2I
VVN
W2D
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
YOC
YSK
YYM
YZZ
ZFV
ZY1
~H1
AAFWJ
AAYXX
CITATION
ACIJW
AWKKM
NPM
ODA
OJAPA
OLW
RHF
7X8
ID FETCH-LOGICAL-c4018-e6f4aece44dc09a2f977631b259875173f0c1e1753af2ecb70dab64713605fc43
ISSN 0009-7322
1524-4539
IngestDate Fri Jul 11 10:50:38 EDT 2025
Wed Feb 19 02:28:25 EST 2025
Thu Apr 24 22:58:10 EDT 2025
Tue Jul 01 04:15:49 EDT 2025
Fri May 16 03:49:03 EDT 2025
Fri May 16 03:51:50 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 25
Keywords occupation
risk stratification
echocardiography
systolic dysfunction
sudden cardiac death
left ventricular outflow tract obstruction
septal alcohol ablation
AHA Scientific Statements
sarcomeric genes
atrial fibrillation
genetics
shared decision-making
guidelines
family screening
rhythm monitoring
pregnancy
septal reduction therapy
cardiovascular magnetic resonance
physical activity
exercise stress testing
implantable cardioverter defibrillator
surgical myectomy
ventricular arrhythmias
diastolic dysfunction
hypertrophic cardiomyopathy
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4018-e6f4aece44dc09a2f977631b259875173f0c1e1753af2ecb70dab64713605fc43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
ObjectType-Review-4
content type line 23
PMID 33215938
PQID 2463099212
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2463099212
pubmed_primary_33215938
crossref_primary_10_1161_CIR_0000000000000938
crossref_citationtrail_10_1161_CIR_0000000000000938
wolterskluwer_health_10_1161_CIR_0000000000000938
wolterskluwer_health_00003017-202012220-00019
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2020-December-22
PublicationDateYYYYMMDD 2020-12-22
PublicationDate_xml – month: 12
  year: 2020
  text: 2020-December-22
  day: 22
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Circulation (New York, N.Y.)
PublicationTitleAlternate Circulation
PublicationYear 2020
Publisher by the American College of Cardiology Foundation and the American Heart Association, Inc
Publisher_xml – name: by the American College of Cardiology Foundation and the American Heart Association, Inc
References e_1_3_2_232_2
e_1_3_2_255_2
e_1_3_2_278_2
Nguyen A (e_1_3_2_249_2) 2019
e_1_3_2_195_2
e_1_3_2_217_2
e_1_3_2_172_2
e_1_3_2_62_2
e_1_3_2_85_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_100_2
e_1_3_2_123_2
e_1_3_2_146_2
e_1_3_2_169_2
e_1_3_2_281_2
e_1_3_2_315_2
e_1_3_2_108_2
e_1_3_2_220_2
e_1_3_2_266_2
e_1_3_2_289_2
e_1_3_2_7_2
Agency for Healthcare Research and Quality (e_1_3_2_6_2)
e_1_3_2_161_2
e_1_3_2_184_2
e_1_3_2_228_2
e_1_3_2_73_2
e_1_3_2_205_2
e_1_3_2_12_2
e_1_3_2_58_2
e_1_3_2_96_2
e_1_3_2_35_2
e_1_3_2_112_2
e_1_3_2_135_2
e_1_3_2_158_2
e_1_3_2_50_2
e_1_3_2_196_2
e_1_3_2_303_2
e_1_3_2_292_2
e_1_3_2_48_2
e_1_3_2_210_2
e_1_3_2_256_2
e_1_3_2_279_2
e_1_3_2_233_2
e_1_3_2_40_2
e_1_3_2_86_2
e_1_3_2_218_2
e_1_3_2_171_2
e_1_3_2_63_2
e_1_3_2_25_2
e_1_3_2_145_2
e_1_3_2_168_2
e_1_3_2_122_2
e_1_3_2_316_2
e_1_3_2_282_2
e_1_3_2_107_2
e_1_3_2_221_2
e_1_3_2_267_2
e_1_3_2_59_2
e_1_3_2_244_2
e_1_3_2_206_2
e_1_3_2_229_2
e_1_3_2_183_2
e_1_3_2_51_2
e_1_3_2_74_2
e_1_3_2_160_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_97_2
e_1_3_2_134_2
e_1_3_2_157_2
e_1_3_2_111_2
e_1_3_2_270_2
e_1_3_2_293_2
e_1_3_2_304_2
e_1_3_2_119_2
Kolb C (e_1_3_2_192_2) 2014; 2
e_1_3_2_257_2
Agency for Healthcare Research and Quality (e_1_3_2_5_2)
e_1_3_2_211_2
e_1_3_2_234_2
e_1_3_2_295_2
e_1_3_2_151_2
e_1_3_2_22_2
e_1_3_2_45_2
e_1_3_2_68_2
e_1_3_2_219_2
Defaye P (e_1_3_2_194_2) 2017; 19
e_1_3_2_125_2
e_1_3_2_148_2
e_1_3_2_60_2
e_1_3_2_83_2
e_1_3_2_102_2
e_1_3_2_163_2
e_1_3_2_186_2
e_1_3_2_260_2
e_1_3_2_268_2
e_1_3_2_18_2
e_1_3_2_222_2
e_1_3_2_245_2
e_1_3_2_207_2
e_1_3_2_140_2
e_1_3_2_10_2
e_1_3_2_33_2
e_1_3_2_79_2
e_1_3_2_56_2
e_1_3_2_114_2
e_1_3_2_137_2
e_1_3_2_320_2
e_1_3_2_94_2
e_1_3_2_71_2
e_1_3_2_152_2
e_1_3_2_175_2
e_1_3_2_294_2
e_1_3_2_198_2
e_1_3_2_305_2
e_1_3_2_271_2
e_1_3_2_258_2
e_1_3_2_235_2
e_1_3_2_273_2
e_1_3_2_212_2
e_1_3_2_296_2
e_1_3_2_150_2
e_1_3_2_173_2
e_1_3_2_84_2
e_1_3_2_23_2
e_1_3_2_69_2
e_1_3_2_46_2
Gu M (e_1_3_2_201_2) 2017; 14
e_1_3_2_124_2
e_1_3_2_147_2
e_1_3_2_310_2
e_1_3_2_61_2
e_1_3_2_101_2
e_1_3_2_185_2
e_1_3_2_109_2
e_1_3_2_261_2
e_1_3_2_318_2
e_1_3_2_269_2
e_1_3_2_19_2
e_1_3_2_246_2
e_1_3_2_284_2
e_1_3_2_223_2
e_1_3_2_162_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_57_2
e_1_3_2_95_2
e_1_3_2_4_2
Igarashi M (e_1_3_2_283_2) 2018; 4
e_1_3_2_208_2
e_1_3_2_113_2
e_1_3_2_159_2
e_1_3_2_136_2
e_1_3_2_72_2
e_1_3_2_321_2
e_1_3_2_174_2
e_1_3_2_197_2
e_1_3_2_272_2
e_1_3_2_306_2
e_1_3_2_28_2
e_1_3_2_191_2
e_1_3_2_213_2
e_1_3_2_236_2
e_1_3_2_251_2
e_1_3_2_274_2
e_1_3_2_297_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_259_2
e_1_3_2_66_2
e_1_3_2_89_2
e_1_3_2_104_2
e_1_3_2_142_2
e_1_3_2_165_2
e_1_3_2_188_2
e_1_3_2_311_2
e_1_3_2_81_2
e_1_3_2_127_2
e_1_3_2_319_2
e_1_3_2_16_2
e_1_3_2_39_2
e_1_3_2_224_2
e_1_3_2_247_2
e_1_3_2_262_2
e_1_3_2_285_2
e_1_3_2_54_2
e_1_3_2_31_2
e_1_3_2_180_2
e_1_3_2_3_2
e_1_3_2_77_2
e_1_3_2_209_2
e_1_3_2_92_2
e_1_3_2_131_2
e_1_3_2_154_2
e_1_3_2_177_2
e_1_3_2_322_2
e_1_3_2_250_2
Qin JX (e_1_3_2_67_2) 2001; 38
e_1_3_2_116_2
e_1_3_2_139_2
e_1_3_2_307_2
e_1_3_2_190_2
e_1_3_2_29_2
e_1_3_2_214_2
e_1_3_2_252_2
e_1_3_2_298_2
e_1_3_2_275_2
e_1_3_2_21_2
e_1_3_2_237_2
e_1_3_2_44_2
e_1_3_2_126_2
e_1_3_2_82_2
e_1_3_2_103_2
e_1_3_2_141_2
e_1_3_2_187_2
e_1_3_2_312_2
e_1_3_2_164_2
e_1_3_2_149_2
Fumagalli C (e_1_3_2_317_2) 2019
e_1_3_2_17_2
e_1_3_2_240_2
e_1_3_2_202_2
e_1_3_2_225_2
e_1_3_2_263_2
e_1_3_2_286_2
e_1_3_2_32_2
e_1_3_2_248_2
e_1_3_2_55_2
e_1_3_2_78_2
e_1_3_2_93_2
e_1_3_2_115_2
e_1_3_2_130_2
e_1_3_2_176_2
e_1_3_2_300_2
e_1_3_2_70_2
e_1_3_2_153_2
e_1_3_2_323_2
e_1_3_2_199_2
e_1_3_2_138_2
e_1_3_2_308_2
e_1_3_2_26_2
e_1_3_2_49_2
e_1_3_2_230_2
e_1_3_2_299_2
e_1_3_2_193_2
e_1_3_2_253_2
e_1_3_2_276_2
e_1_3_2_41_2
e_1_3_2_64_2
e_1_3_2_87_2
e_1_3_2_215_2
e_1_3_2_238_2
e_1_3_2_170_2
e_1_3_2_167_2
e_1_3_2_121_2
e_1_3_2_144_2
e_1_3_2_313_2
e_1_3_2_106_2
e_1_3_2_129_2
e_1_3_2_9_2
e_1_3_2_37_2
e_1_3_2_241_2
e_1_3_2_264_2
e_1_3_2_287_2
Rowin EJ (e_1_3_2_203_2) 2019; 5
e_1_3_2_75_2
e_1_3_2_182_2
e_1_3_2_52_2
e_1_3_2_226_2
e_1_3_2_14_2
e_1_3_2_98_2
e_1_3_2_156_2
e_1_3_2_179_2
e_1_3_2_110_2
e_1_3_2_133_2
e_1_3_2_301_2
e_1_3_2_324_2
e_1_3_2_90_2
e_1_3_2_290_2
e_1_3_2_118_2
e_1_3_2_309_2
e_1_3_2_27_2
e_1_3_2_231_2
e_1_3_2_277_2
e_1_3_2_254_2
e_1_3_2_65_2
e_1_3_2_239_2
e_1_3_2_42_2
e_1_3_2_216_2
e_1_3_2_88_2
e_1_3_2_189_2
e_1_3_2_120_2
e_1_3_2_166_2
Pacileo G (e_1_3_2_243_2) 2000; 16
e_1_3_2_80_2
e_1_3_2_143_2
e_1_3_2_314_2
Ommen S (e_1_3_2_2_2) 2020
e_1_3_2_280_2
e_1_3_2_105_2
e_1_3_2_128_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_242_2
e_1_3_2_288_2
e_1_3_2_265_2
e_1_3_2_30_2
e_1_3_2_53_2
e_1_3_2_76_2
e_1_3_2_99_2
e_1_3_2_204_2
e_1_3_2_227_2
e_1_3_2_181_2
e_1_3_2_91_2
e_1_3_2_178_2
Killu AM (e_1_3_2_200_2) 2018; 20
e_1_3_2_155_2
e_1_3_2_132_2
e_1_3_2_302_2
e_1_3_2_291_2
e_1_3_2_117_2
References_xml – ident: e_1_3_2_16_2
  doi: 10.1016/j.jacc.2015.01.019
– ident: e_1_3_2_87_2
  doi: 10.1016/j.jacc.2018.05.060
– ident: e_1_3_2_41_2
  doi: 10.1016/j.jacc.2012.03.076
– ident: e_1_3_2_169_2
  doi: 10.1016/j.jacc.2015.03.552
– ident: e_1_3_2_83_2
  doi: 10.1007/s10554-013-0355-y
– ident: e_1_3_2_176_2
  doi: 10.1161/JAHA.115.002418
– ident: e_1_3_2_198_2
  doi: 10.1161/01.CIR.99.22.2927
– ident: e_1_3_2_73_2
  doi: 10.1016/S0894-7317(00)90026-9
– ident: e_1_3_2_159_2
  doi: 10.1016/j.echo.2011.03.002
– ident: e_1_3_2_90_2
  doi: 10.1016/j.amjcard.2018.06.055
– ident: e_1_3_2_306_2
  doi: 10.1002/ejhf.316
– ident: e_1_3_2_150_2
  doi: 10.1161/circulationaha.108.798314
– ident: e_1_3_2_252_2
  doi: 10.1016/j.chest.2018.11.009
– ident: e_1_3_2_21_2
  doi: 10.1161/circep.110.957290
– ident: e_1_3_2_206_2
  doi: 10.1136/hrt.32.6.804
– ident: e_1_3_2_229_2
  doi: 10.1111/jth.12780
– ident: e_1_3_2_22_2
  doi: 10.1016/j.amjcard.2017.12.044
– ident: e_1_3_2_215_2
  doi: 10.1016/0002-9149(62)90373-9
– ident: e_1_3_2_18_2
  doi: 10.1016/j.jacc.2005.02.090
– ident: e_1_3_2_168_2
  doi: 10.1016/S0735-1097(98)00493-8
– ident: e_1_3_2_25_2
  doi: 10.1016/j.hrthm.2011.07.017
– ident: e_1_3_2_62_2
  doi: 10.1016/j.jcmg.2015.04.006
– ident: e_1_3_2_156_2
  doi: 10.1016/j.jjcc.2014.02.011
– ident: e_1_3_2_195_2
  doi: 10.1016/j.hlc.2015.07.008
– ident: e_1_3_2_76_2
  doi: 10.1161/circulationaha.104.507723
– ident: e_1_3_2_121_2
  doi: 10.1016/j.jacc.2018.04.078
– ident: e_1_3_2_131_2
  doi: 10.1056/NEJMoa075463
– ident: e_1_3_2_231_2
  doi: 10.1093/eurheartj/ehm117
– volume: 14
  start-page: 238
  year: 2017
  ident: e_1_3_2_201_2
  article-title: Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy.
  publication-title: J Geriatr Cardiol
– ident: e_1_3_2_98_2
  doi: 10.1136/bjsports-2016-097438
– ident: e_1_3_2_12_2
  doi: 10.1016/j.amjcard.2014.07.075
– ident: e_1_3_2_47_2
  doi: 10.1161/circulationaha.107.742395
– ident: e_1_3_2_123_2
  doi: 10.1161/CIRCGEN.119.002460
– ident: e_1_3_2_154_2
  doi: 10.1016/j.jacc.2004.12.067
– ident: e_1_3_2_255_2
  doi: 10.1093/eurheartj/ehx731
– ident: e_1_3_2_39_2
  doi: 10.1161/circulationaha.105.583500
– ident: e_1_3_2_144_2
  doi: 10.1038/s41436-019-0478-1
– ident: e_1_3_2_274_2
  doi: 10.1093/ejcts/ezx017
– ident: e_1_3_2_29_2
  doi: 10.1093/eurheartj/ehz396
– ident: e_1_3_2_207_2
  doi: 10.1016/0002-9149(73)90012-X
– ident: e_1_3_2_125_2
  doi: 10.1001/jama.2009.371
– ident: e_1_3_2_237_2
  doi: 10.1016/j.mayocp.2018.07.022
– ident: e_1_3_2_268_2
  doi: 10.1111/pace.13310
– ident: e_1_3_2_220_2
  doi: 10.1016/j.jacc.2018.09.064
– ident: e_1_3_2_273_2
  doi: 10.1016/j.jtcvs.2017.08.063
– ident: e_1_3_2_235_2
  doi: 10.1016/j.jtcvs.2018.11.148
– ident: e_1_3_2_289_2
  doi: 10.1016/j.healun.2015.03.012
– ident: e_1_3_2_35_2
  doi: 10.1016/j.echo.2011.03.006
– ident: e_1_3_2_14_2
  doi: 10.1038/nrcardio.2017.6
– ident: e_1_3_2_259_2
  doi: 10.1016/j.hrthm.2015.03.042
– ident: e_1_3_2_135_2
  doi: 10.1056/NEJMoa1510687
– ident: e_1_3_2_133_2
  doi: 10.1093/eurheartj/ehr092
– ident: e_1_3_2_145_2
– ident: e_1_3_2_204_2
  doi: 10.1016/j.jacc.2017.11.040
– ident: e_1_3_2_222_2
  doi: 10.1161/CIRCINTERVENTIONS.118.007673
– ident: e_1_3_2_184_2
  doi: 10.1161/CIRCEP.117.004801
– ident: e_1_3_2_210_2
  doi: 10.1536/ihj.27.701
– ident: e_1_3_2_279_2
  doi: 10.1097/FJC.0b013e31829651fe
– ident: e_1_3_2_30_2
  doi: 10.1016/j.amjcard.2006.07.029
– ident: e_1_3_2_58_2
  doi: 10.1016/j.echo.2017.11.016
– ident: e_1_3_2_218_2
  doi: 10.1016/j.jtcvs.2011.10.096
– ident: e_1_3_2_208_2
  doi: 10.1161/01.CIR.64.4.787
– ident: e_1_3_2_51_2
  doi: 10.1161/circulationaha.106.644682
– ident: e_1_3_2_108_2
  doi: 10.1016/j.jcin.2011.02.014
– ident: e_1_3_2_95_2
  doi: 10.1016/j.ejrad.2014.05.035
– ident: e_1_3_2_77_2
  doi: 10.1136/hrt.2003.014969
– ident: e_1_3_2_164_2
  doi: 10.1016/j.ahj.2013.06.009
– ident: e_1_3_2_53_2
  doi: 10.1093/ejechocard/jeq063
– ident: e_1_3_2_93_2
  doi: 10.1016/j.amjcard.2013.01.340
– ident: e_1_3_2_146_2
  doi: 10.1016/j.ijcard.2011.07.095
– ident: e_1_3_2_262_2
  doi: 10.1093/europace/eux163
– volume: 38
  start-page: 1994
  year: 2001
  ident: e_1_3_2_67_2
  article-title: Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
  publication-title: J Am Coll Cardiol
– ident: e_1_3_2_96_2
  doi: 10.1111/j.1542-474X.2001.tb00118.x
– ident: e_1_3_2_221_2
  doi: 10.1016/j.jtcvs.2018.08.062
– ident: e_1_3_2_97_2
  doi: 10.1016/0002-9149(89)90187-2
– ident: e_1_3_2_265_2
  doi: 10.1111/j.1540-8167.2008.01320.x
– ident: e_1_3_2_295_2
  doi: 10.1161/CIR.0000000000000678
– ident: e_1_3_2_128_2
  doi: 10.1038/gim.2015.30
– ident: e_1_3_2_37_2
  doi: 10.1093/eurheartj/ehq136
– ident: e_1_3_2_68_2
  doi: 10.1161/CIRCULATIONAHA.111.090514
– ident: e_1_3_2_246_2
  doi: 10.1093/eurheartj/ehs150
– ident: e_1_3_2_147_2
  doi: 10.1001/jamacardio.2019.1391
– ident: e_1_3_2_45_2
  doi: 10.1161/01.cir.0000162460.36735.71
– ident: e_1_3_2_297_2
– ident: e_1_3_2_49_2
  doi: 10.1016/S0002-9149(99)80416-0
– ident: e_1_3_2_50_2
  doi: 10.1016/j.echo.2010.10.006
– ident: e_1_3_2_199_2
  doi: 10.1023/B:JICE.0000035929.84238.2f
– ident: e_1_3_2_122_2
  doi: 10.1161/CIRCULATIONAHA.117.033200
– ident: e_1_3_2_261_2
  doi: 10.1093/eurheartj/ehx042
– ident: e_1_3_2_141_2
  doi: 10.1038/gim.2012.19
– ident: e_1_3_2_300_2
  doi: 10.1016/j.ijcard.2017.07.015
– ident: e_1_3_2_285_2
  doi: 10.1016/j.mayocp.2016.01.002
– ident: e_1_3_2_197_2
  doi: 10.1093/oxfordjournals.eurheartj.a015435
– ident: e_1_3_2_85_2
  doi: 10.1016/j.jcmg.2016.02.031
– ident: e_1_3_2_42_2
  doi: 10.1093/europace/euz118
– ident: e_1_3_2_89_2
  doi: 10.1161/circimaging.115.003132
– ident: e_1_3_2_232_2
  doi: 10.1161/CIR.0000000000000503
– ident: e_1_3_2_302_2
  doi: 10.1161/CIRCULATIONAHA.117.031306
– ident: e_1_3_2_219_2
  doi: 10.1016/j.athoracsur.2009.10.065
– ident: e_1_3_2_44_2
  doi: 10.1056/NEJMoa021332
– ident: e_1_3_2_57_2
  doi: 10.1016/0735-1097(92)90359-U
– ident: e_1_3_2_307_2
  doi: 10.1093/eurheartj/ehy340
– ident: e_1_3_2_81_2
  doi: 10.1161/CIRCIMAGING.116.005372
– ident: e_1_3_2_110_2
  doi: 10.1016/j.amjcard.2007.09.111
– ident: e_1_3_2_245_2
  doi: 10.1016/0735-1097(93)90386-F
– ident: e_1_3_2_304_2
– ident: e_1_3_2_137_2
  doi: 10.1056/NEJMsa1507092
– ident: e_1_3_2_180_2
  doi: 10.1093/eurheartj/ehu112
– ident: e_1_3_2_183_2
  doi: 10.1161/JAHA.115.002488
– ident: e_1_3_2_91_2
  doi: 10.1016/j.jacc.2016.01.071
– start-page: 1
  year: 2019
  ident: e_1_3_2_317_2
  article-title: Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy.
  publication-title: JAMA Cardiol
– ident: e_1_3_2_34_2
  doi: 10.1016/S0735-1097(83)80269-1
– ident: e_1_3_2_148_2
  doi: 10.1161/CIRCULATIONAHA.117.030437
– ident: e_1_3_2_175_2
  doi: 10.1161/CIRCULATIONAHA.117.027828
– ident: e_1_3_2_305_2
  doi: 10.1136/heartjnl-2018-313058
– ident: e_1_3_2_124_2
  doi: 10.1161/CIRCGENETICS.117.001916
– ident: e_1_3_2_138_2
  doi: 10.1111/cge.13157
– ident: e_1_3_2_56_2
  doi: 10.1016/0735-1097(92)90135-A
– ident: e_1_3_2_69_2
– ident: e_1_3_2_320_2
  doi: 10.1093/eurheartj/ehv522
– ident: e_1_3_2_61_2
  doi: 10.1067/mje.2000.108250
– ident: e_1_3_2_193_2
  doi: 10.1161/JAHA.117.006937
– ident: e_1_3_2_309_2
  doi: 10.1016/j.ajog.2019.07.019
– ident: e_1_3_2_24_2
  doi: 10.1016/j.jacc.2012.02.068
– ident: e_1_3_2_161_2
  doi: 10.1161/CIRCULATIONAHA.119.044366
– ident: e_1_3_2_179_2
  doi: 10.1136/hrt.2010.217182
– ident: e_1_3_2_149_2
  doi: 10.1016/S0735-1097(99)00056-X
– ident: e_1_3_2_213_2
  doi: 10.1161/JAHA.116.005152
– ident: e_1_3_2_63_2
  doi: 10.1016/j.euje.2004.01.001
– ident: e_1_3_2_209_2
  doi: 10.1161/01.CIR.60.6.1208
– ident: e_1_3_2_277_2
  doi: 10.1016/j.hrthm.2016.03.004
– ident: e_1_3_2_313_2
  doi: 10.1016/S0735-1097(02)02495-6
– ident: e_1_3_2_167_2
  doi: 10.1007/s00246-011-9967-y
– volume: 20
  start-page: 82
  year: 2018
  ident: e_1_3_2_200_2
  article-title: Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
  publication-title: Eur J Echocardiogr
– ident: e_1_3_2_74_2
  doi: 10.1016/j.echo.2017.11.013
– ident: e_1_3_2_115_2
  doi: 10.1253/circj.CJ-16-0432
– ident: e_1_3_2_46_2
  doi: 10.1161/CIRCULATIONAHA.107.698985
– ident: e_1_3_2_94_2
  doi: 10.1007/s10554-013-0358-8
– ident: e_1_3_2_247_2
  doi: 10.1161/01.CIR.67.2.413
– ident: e_1_3_2_120_2
  doi: 10.1038/gim.2014.205
– ident: e_1_3_2_31_2
  doi: 10.1016/j.jcmg.2008.09.002
– ident: e_1_3_2_126_2
  doi: 10.1161/circimaging.110.957936
– ident: e_1_3_2_132_2
– ident: e_1_3_2_160_2
  doi: 10.1016/j.jacc.2020.04.045
– ident: e_1_3_2_308_2
  doi: 10.1007/s12471-012-0358-7
– ident: e_1_3_2_165_2
  doi: 10.1016/j.jacc.2013.01.037
– ident: e_1_3_2_186_2
  doi: 10.1016/j.hrthm.2017.11.020
– ident: e_1_3_2_258_2
  doi: 10.1093/europace/euv339
– ident: e_1_3_2_272_2
  doi: 10.1016/j.amjcard.2003.10.025
– ident: e_1_3_2_188_2
  doi: 10.1253/circj.CJ-16-0428
– ident: e_1_3_2_254_2
  doi: 10.1016/j.ijcard.2017.08.010
– ident: e_1_3_2_158_2
  doi: 10.1093/eurheartj/eht439
– ident: e_1_3_2_54_2
  doi: 10.1093/ehjci/jew313
– ident: e_1_3_2_173_2
  doi: 10.1016/j.amjcard.2013.12.034
– ident: e_1_3_2_38_2
  doi: 10.1136/hrt.2003.031161
– ident: e_1_3_2_88_2
  doi: 10.1136/heartjnl-2013-305471
– ident: e_1_3_2_269_2
  doi: 10.1016/j.amjcard.2019.02.051
– ident: e_1_3_2_271_2
  doi: 10.1161/circep.113.000339
– ident: e_1_3_2_32_2
  doi: 10.1016/0735-1097(95)00390-8
– ident: e_1_3_2_155_2
  doi: 10.1016/S0140-6736(00)04005-8
– ident: e_1_3_2_224_2
  doi: 10.1093/ehjci/jew024
– ident: e_1_3_2_211_2
  doi: 10.1016/j.jacc.2005.01.012
– ident: e_1_3_2_205_2
  doi: 10.1161/01.CIR.35.5.847
– volume-title: AHRQ Health Literacy Universal Precautions Toolkit
  ident: e_1_3_2_6_2
– ident: e_1_3_2_293_2
  doi: 10.1001/jama.2017.2503
– ident: e_1_3_2_316_2
  doi: 10.1016/j.jacc.2013.03.062
– ident: e_1_3_2_263_2
  doi: 10.1161/CIRCULATIONAHA.115.020252
– ident: e_1_3_2_296_2
  doi: 10.1161/CIRCULATIONAHA.117.029639
– ident: e_1_3_2_214_2
  doi: 10.1016/j.jacc.2015.06.1333
– ident: e_1_3_2_59_2
  doi: 10.1016/S0002-9149(02)02694-2
– ident: e_1_3_2_294_2
  doi: 10.1016/j.amjcard.2018.05.023
– ident: e_1_3_2_267_2
  doi: 10.1161/JAHA.116.005152
– ident: e_1_3_2_212_2
  doi: 10.1161/CIRCHEARTFAILURE.112.000122
– ident: e_1_3_2_13_2
  doi: 10.1161/circulationaha.111.076257
– ident: e_1_3_2_43_2
  doi: 10.1016/j.hrthm.2019.04.040
– ident: e_1_3_2_143_2
  doi: 10.1038/s41436-018-0391-z
– ident: e_1_3_2_303_2
  doi: 10.1093/eurheartj/ehu284
– ident: e_1_3_2_142_2
– ident: e_1_3_2_216_2
  doi: 10.1136/adc.62.12.1265
– ident: e_1_3_2_187_2
  doi: 10.1111/jce.13121
– volume: 2
  start-page: 611
  year: 2014
  ident: e_1_3_2_192_2
  article-title: Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
  publication-title: J Am Coll Cardiol HF
– ident: e_1_3_2_9_2
  doi: 10.1097/00005650-198903001-00010
– ident: e_1_3_2_101_2
  doi: 10.1016/j.jacc.2004.11.043
– ident: e_1_3_2_109_2
  doi: 10.1002/ccd.26472
– ident: e_1_3_2_324_2
  doi: 10.1016/j.hrthm.2018.12.017
– ident: e_1_3_2_26_2
  doi: 10.1161/HCG.0000000000000054
– ident: e_1_3_2_65_2
  doi: 10.1161/circulationaha.107.738740
– ident: e_1_3_2_140_2
  doi: 10.1136/jmg.2005.033886
– ident: e_1_3_2_178_2
  doi: 10.1016/j.hrthm.2008.08.021
– ident: e_1_3_2_256_2
  doi: 10.1161/hc4601.097997
– ident: e_1_3_2_298_2
  doi: 10.1093/eurheartj/ehy730
– ident: e_1_3_2_127_2
– ident: e_1_3_2_312_2
  doi: 10.1016/j.acvd.2017.05.010
– ident: e_1_3_2_106_2
  doi: 10.1016/j.amjcard.2017.02.040
– ident: e_1_3_2_153_2
  doi: 10.1056/NEJM200006153422403
– volume: 16
  start-page: 146
  year: 2000
  ident: e_1_3_2_243_2
  article-title: Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function.
  publication-title: Can J Cardiol
– ident: e_1_3_2_189_2
  doi: 10.1111/j.1540-8167.2010.01943.x
– ident: e_1_3_2_281_2
  doi: 10.1093/europace/euw260
– ident: e_1_3_2_111_2
  doi: 10.1161/01.cir.0000097110.55312.bf
– volume: 5
  start-page: 131
  year: 2019
  ident: e_1_3_2_203_2
  article-title: Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy.
  publication-title: J Am Coll Cardiol EP
– ident: e_1_3_2_226_2
  doi: 10.1016/j.athoracsur.2018.03.039
– ident: e_1_3_2_118_2
  doi: 10.1093/eurheartj/ehq271
– ident: e_1_3_2_71_2
  doi: 10.1161/CIRCULATIONAHA.118.038846
– ident: e_1_3_2_280_2
  doi: 10.1111/jce.13194
– ident: e_1_3_2_288_2
  doi: 10.1016/j.transproceed.2013.12.052
– ident: e_1_3_2_114_2
  doi: 10.1161/circheartfailure.114.002248
– ident: e_1_3_2_238_2
  doi: 10.1016/j.jacc.2016.07.735
– ident: e_1_3_2_7_2
  doi: 10.1007/BF02595921
– ident: e_1_3_2_99_2
  doi: 10.1016/0002-9149(81)90604-4
– ident: e_1_3_2_230_2
  doi: 10.1016/j.jtcvs.2018.03.150
– ident: e_1_3_2_181_2
  doi: 10.1016/j.hrthm.2016.01.001
– ident: e_1_3_2_314_2
  doi: 10.1093/eurheartj/ehw210
– ident: e_1_3_2_191_2
  doi: 10.1016/j.jacc.2004.09.039
– ident: e_1_3_2_17_2
  doi: 10.1016/j.jacc.2014.05.003
– ident: e_1_3_2_70_2
  doi: 10.1161/CIRCULATIONAHA.118.037264
– ident: e_1_3_2_270_2
  doi: 10.1136/heartjnl-2016-309406
– ident: e_1_3_2_170_2
  doi: 10.1007/s00246-013-0676-6
– start-page: S0022-5223(19)3
  year: 2019
  ident: e_1_3_2_249_2
  article-title: Apical myectomy for patients with hypertrophic cardiomyopathy and advanced heart failure.
  publication-title: J Thorac Cardiovasc Surg
– ident: e_1_3_2_113_2
  doi: 10.1016/S0735-1097(02)01950-2
– ident: e_1_3_2_20_2
  doi: 10.1111/j.1540-8167.2008.01366.x
– ident: e_1_3_2_23_2
  doi: 10.1161/circheartfailure.114.001843
– ident: e_1_3_2_234_2
  doi: 10.1016/j.jacc.2011.08.040
– ident: e_1_3_2_130_2
– ident: e_1_3_2_248_2
  doi: 10.1016/S2213-8587(14)70241-4
– ident: e_1_3_2_172_2
  doi: 10.1161/CIRCULATIONAHA.120.047235
– ident: e_1_3_2_166_2
  doi: 10.1177/2047487317702519
– ident: e_1_3_2_202_2
  doi: 10.1016/j.ejheart.2008.03.006
– ident: e_1_3_2_36_2
  doi: 10.1016/j.jacc.2010.11.002
– ident: e_1_3_2_86_2
  doi: 10.1161/circulationaha.113.007094
– ident: e_1_3_2_282_2
  doi: 10.1016/j.hrthm.2010.05.022
– ident: e_1_3_2_11_2
  doi: 10.1001/jamacardio.2016.0252
– ident: e_1_3_2_239_2
  doi: 10.1016/0002-8703(85)90357-6
– ident: e_1_3_2_80_2
  doi: 10.1016/j.amjcard.2016.11.010
– ident: e_1_3_2_119_2
  doi: 10.1038/gim.2013.44
– ident: e_1_3_2_79_2
  doi: 10.1007/s10554-016-0858-4
– ident: e_1_3_2_40_2
  doi: 10.1161/circheartfailure.112.967026
– ident: e_1_3_2_117_2
– ident: e_1_3_2_52_2
  doi: 10.1016/j.amjcard.2017.08.047
– ident: e_1_3_2_217_2
  doi: 10.1097/HCO.0000000000000200
– ident: e_1_3_2_3_2
  doi: 10.1161/CIR.0b013e318223e2bd
– ident: e_1_3_2_152_2
  doi: 10.1093/eurheartj/ehq308
– ident: e_1_3_2_240_2
  doi: 10.1136/hrt.48.3.204
– ident: e_1_3_2_19_2
  doi: 10.1161/circulationaha.112.000849
– ident: e_1_3_2_163_2
  doi: 10.1001/jama.298.4.405
– ident: e_1_3_2_275_2
  doi: 10.1161/circheartfailure.114.001435
– ident: e_1_3_2_242_2
  doi: 10.1161/01.CIR.79.5.1052
– ident: e_1_3_2_134_2
  doi: 10.1093/eurheartj/ehv063
– ident: e_1_3_2_27_2
  doi: 10.1161/CIRCGEN.117.001896
– ident: e_1_3_2_253_2
  doi: 10.1016/j.jacc.2016.04.026
– ident: e_1_3_2_287_2
  doi: 10.1016/j.amjcard.2012.04.030
– ident: e_1_3_2_318_2
  doi: 10.3390/jcm7110447
– ident: e_1_3_2_257_2
  doi: 10.1093/eurheartj/eht491
– ident: e_1_3_2_301_2
  doi: 10.1161/CIRCULATIONAHA.117.031725
– ident: e_1_3_2_278_2
  doi: 10.1111/j.1540-8167.2011.02183.x
– ident: e_1_3_2_75_2
  doi: 10.1016/j.jacc.2009.05.006
– ident: e_1_3_2_185_2
  doi: 10.1016/j.hrthm.2017.06.022
– ident: e_1_3_2_182_2
  doi: 10.1007/s00392-015-0901-9
– ident: e_1_3_2_286_2
  doi: 10.1016/j.amjcard.2017.08.048
– ident: e_1_3_2_84_2
  doi: 10.1016/j.amjcard.2010.01.367
– ident: e_1_3_2_105_2
  doi: 10.1161/circulationaha.117.029267
– ident: e_1_3_2_236_2
  doi: 10.1016/j.jacc.2019.05.053
– ident: e_1_3_2_103_2
  doi: 10.1111/jce.12982
– year: 2020
  ident: e_1_3_2_2_2
  article-title: 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
  publication-title: Circulation
– ident: e_1_3_2_60_2
  doi: 10.1002/(SICI)1522-726X(199908)47:4<462::AID-CCD16>3.0.CO;2-9
– ident: e_1_3_2_299_2
  doi: 10.1161/circulationaha.112.000447
– ident: e_1_3_2_284_2
  doi: 10.1161/cir.0b013e31829e8776
– ident: e_1_3_2_241_2
  doi: 10.1136/hrt.56.6.544
– ident: e_1_3_2_276_2
  doi: 10.1001/jama.295.2.165
– ident: e_1_3_2_315_2
  doi: 10.1016/j.amjcard.2013.05.070
– ident: e_1_3_2_100_2
  doi: 10.1016/S0735-1097(03)00827-1
– ident: e_1_3_2_196_2
  doi: 10.1016/S0735-1097(96)00473-1
– ident: e_1_3_2_323_2
  doi: 10.1378/chest.14-1498
– ident: e_1_3_2_129_2
  doi: 10.1111/cge.13024
– volume: 19
  start-page: 1478
  year: 2017
  ident: e_1_3_2_194_2
  article-title: Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the defibrillateur automatique implantable-prevention primaire registry.
  publication-title: Eur J Echocardiogr
– ident: e_1_3_2_292_2
  doi: 10.1161/circheartfailure.110.959288
– ident: e_1_3_2_190_2
  doi: 10.1161/circulationaha.105.594531
– ident: e_1_3_2_55_2
  doi: 10.1136/hrt.2007.126003
– ident: e_1_3_2_310_2
  doi: 10.1093/eurheartj/ehx189
– ident: e_1_3_2_66_2
  doi: 10.1161/01.CIR.98.22.2415
– ident: e_1_3_2_311_2
  doi: 10.1136/heart.89.7.752
– ident: e_1_3_2_291_2
  doi: 10.1016/j.cardfail.2017.09.011
– ident: e_1_3_2_322_2
  doi: 10.1016/j.amjcard.2010.01.023
– volume-title: In: The CAHPS Ambulatory Care Improvement Guide: Practical Strategies for Improving Patient Experience
  ident: e_1_3_2_5_2
– ident: e_1_3_2_78_2
  doi: 10.1161/CIRCIMAGING.117.006309
– ident: e_1_3_2_321_2
  doi: 10.1016/j.jacc.2009.07.030
– ident: e_1_3_2_223_2
  doi: 10.1016/j.cpcardiol.2018.10.002
– ident: e_1_3_2_157_2
  doi: 10.1161/circep.116.004604
– ident: e_1_3_2_225_2
  doi: 10.1016/j.jcmg.2013.08.010
– ident: e_1_3_2_28_2
  doi: 10.1161/circulationaha.114.013478
– ident: e_1_3_2_102_2
  doi: 10.1161/CIR.0000000000000499
– ident: e_1_3_2_136_2
  doi: 10.1038/gim.2013.138
– ident: e_1_3_2_72_2
  doi: 10.1016/j.jpeds.2017.03.033
– ident: e_1_3_2_116_2
  doi: 10.1016/j.amjcard.2012.12.026
– ident: e_1_3_2_233_2
  doi: 10.1016/j.jacc.2009.01.079
– ident: e_1_3_2_104_2
  doi: 10.1016/j.amjcard.2016.08.092
– ident: e_1_3_2_227_2
  doi: 10.1111/echo.13158
– ident: e_1_3_2_48_2
  doi: 10.1016/j.echo.2018.01.022
– ident: e_1_3_2_171_2
  doi: 10.1161/circulationaha.115.017633
– ident: e_1_3_2_250_2
  doi: 10.1136/heartjnl-2013-304276
– ident: e_1_3_2_290_2
  doi: 10.1097/MAT.0b013e318286018d
– ident: e_1_3_2_4_2
– ident: e_1_3_2_8_2
  doi: 10.7326/0003-4819-102-4-520
– ident: e_1_3_2_266_2
  doi: 10.1016/S0735-1097(10)80014-2
– ident: e_1_3_2_112_2
  doi: 10.1016/j.jtcvs.2013.06.046
– ident: e_1_3_2_174_2
  doi: 10.1161/CIRCULATIONAHA.117.032966
– ident: e_1_3_2_64_2
  doi: 10.1053/euhj.1999.1692
– ident: e_1_3_2_228_2
  doi: 10.1016/j.amjcard.2015.11.016
– ident: e_1_3_2_139_2
  doi: 10.1161/CIRCGENETICS.116.001620
– ident: e_1_3_2_264_2
  doi: 10.1056/NEJMoa1105575
– ident: e_1_3_2_162_2
  doi: 10.1136/heartjnl-2012-303271
– ident: e_1_3_2_177_2
  doi: 10.1161/circulationaha.110.975219
– ident: e_1_3_2_107_2
  doi: 10.1161/JAHA.114.001002
– volume: 4
  start-page: 339
  year: 2018
  ident: e_1_3_2_283_2
  article-title: Radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy and apical aneurysm.
  publication-title: J Am Coll Cardiol EP
– ident: e_1_3_2_244_2
  doi: 10.1007/BF03164924
– ident: e_1_3_2_33_2
  doi: 10.1016/0033-0620(85)90024-6
– ident: e_1_3_2_82_2
  doi: 10.1016/j.jacc.2016.11.063
– ident: e_1_3_2_10_2
  doi: 10.1016/S0277-9536(98)00059-8
– ident: e_1_3_2_319_2
  doi: 10.1161/CIRCGENETICS.112.963363
– ident: e_1_3_2_260_2
  doi: 10.1161/cir.0000000000000311
– ident: e_1_3_2_92_2
  doi: 10.1136/hrt.2007.118018
– ident: e_1_3_2_151_2
  doi: 10.1016/j.amjcard.2010.06.077
– ident: e_1_3_2_251_2
  doi: 10.1016/S0735-1097(01)01727-2
– ident: e_1_3_2_15_2
  doi: 10.1093/eurheartj/ehx370
SSID ssj0006375
Score 2.6955562
SecondaryResourceType review_article
Snippet AIMThis executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose and...
Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline provides recommendations and algorithms for clinicians to diagnose...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e533
Title 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00003017-202012220-00019
https://www.ncbi.nlm.nih.gov/pubmed/33215938
https://www.proquest.com/docview/2463099212
Volume 142
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFMetbUhoCCHYuIybDhLiZcraOE7a7K10ncq0DgSd1LcocRytgjVTm4rLt-YbcI6dOCmrYNCHqHJTO4l_sc9J_ueYsddxJ8V5OhBOFnuJI1KeOl3Xy5w07gRJKpOsLSkaeXQWDM_FycSfbGxuN1RLyyI5kD_WxpX8T69iGfYrRcn-Q8_aSrEAv2P_4hZ7GLc36mOOVth-b9ijpAj9PnY35awis7HSDh4ZId3UJGIeW1E5Cd9MQlXSvxYX-0N0R-fFPL-6mEoSgaTT_PJ7TssV64xQg29KLrXI6JMJdjMB7cZ6r2QG9uVP42GEqcoExBzbHYZ4exVNMvZP8ikeFkWrTItCKXqF0a9iNj-UgVz1-S2aJnV_OpflGmTrlhZqPki-vDSDrF7KrZZKjmjhFF2uVD1NvV2WwqUysqB-6nsUG4GcVirg1R41H51wLUPhvDnac-EI32RTOlBryqopQvDGvcD9xoivfJPI4_pUFNBU1H_30aTIrD6hSWazmvn77H10fH56Go0Hk_Emu8XR5dGB65NarhR4Omm0PbwyDBRbaa1rY9XMuuY73WF3v-Ykx1h81tEYDZtqfJ_dK50h6BmyH7ANNdthu71ZXCB98Aa0PFnTs8Nuj0oVyC77SVcZkPsWUg-WCkDqAUEESz0g9WCphzyDinog6qFJPaxSfwiWeSiZP4QeGOKpJmqoAhpK4qm8Jr5lf9a8Q4N30LyD5R2wqOIdKt7rM1s8ZOfHg3F_6JRLlzhStN2uo4JMxEoqIVLZDmOeoZsVeG7C_bDb8d2Oh2OgqyhLbpxxJZNOO42TAA1FL2j7mRTeI7Y1y2fqCYPYd5Mw7CTtTIbCp_jeGCdl5dPMGagk3GNe1dORLPP60_IyXyLt3wduhHxEv_Oxxxz7ryuT1-Yv-7-qIIpwAqK3ivFM5ctFxEXgoZuJJvAee2zosjV6HnoUprUV3CIT5K1b8chOJm5cdFV0lgsXz8ldu_-fjvDpDY7wGduux4HnbKuYL9ULdCqK5KW-234BA9QclA
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=2020+AHA%2FACC+Guideline+for+the+Diagnosis+and+Treatment+of+Patients+With+Hypertrophic+Cardiomyopathy%3A+Executive+Summary%3A+A+Report+of+the+American+College+of+Cardiology%2FAmerican+Heart+Association+Joint+Committee+on+Clinical+Practice+Guidelines&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Ommen%2C+Steve+R&rft.au=Mital%2C+Seema&rft.au=Burke%2C+Michael+A&rft.au=Day%2C+Sharlene+M&rft.date=2020-12-22&rft.issn=1524-4539&rft.eissn=1524-4539&rft.volume=142&rft.issue=25&rft.spage=e533&rft_id=info:doi/10.1161%2FCIR.0000000000000938&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7322&client=summon